Li-Fraumeni syndrome is a CPS whereby at least 75% of patients harbor an autosomal-dominant mutation of the tumor suppressor gene TP53, pivotal to the transcription of tumor protein 53 (p53) which regulates the cell cycle (25). The gene discussed is TP53; the disease is Li-Fraumeni syndrome.